Hepcinat-LP (400mg Sofobuvir/90mg ledipasvir) is used to treat Hepatitis C. Hepcinat-LP is the generic version of Harvoni. It is made by Natco Pharma under a license agreement with Gilead Science. Gilead Science is the maker of Harvoni.
BlueSky offers the entire 3 month normal course of treatment for under $3,500.00 as compared to the U.S. Pharmacy cost of over $90,000. Treatment usually consists of 3, 28 day cycles. However, before taking Hepcinat-LP or any other medication your personal physician should be consulted.
Natco Pharma, the makers of Hepcinat-LP was the first company to develop the generic version of Harvoni. With the development of Hepcinat-LP, now a treatment for Hepatitis C is available to persons who are not able to afford the $90,000 outrageously high cost of Harvoni Hepcinat-LP consists of a simple 1-pill per day regimen. In fact Hepcinat-LP is so effective that many patients fly over seas at an additional high costs to purchase Hepcinat-LP.
How Does Hepcinat-LP work?
Hepcinat-LP is a generic version of Harvoni created by Natco Pharma used for the treatment of Hepatitis C. It is widely known as the most effective chronic Hepatitis C treatment.
Hepcinat-LP is a pill made of 90 mg of ledipasvir and 400 mg of sofosbuvir. It manages on itself to cure roughly 90% of hepatitis C patients.
Sofosbuvir mechanism of action is simple enough. Hepatitis C is a virus disease, and virus needs to reproduce in order to survive. Sofosbuvir inhibits viral reproduction by being built in the new virus as an inhibiting building block. Virus needs RNA molecule to reproduce, and sofosbuvir prevents this RNA molecule from forming.
What makes Hepcinat-LP more effective is addition of molecule ledipasvir to sofosbuvir. How Harvoni works is largely based on how sofosbuvir works; but the additional 9% in cure rate is because of ledipasvir mechanism of action.
It’s mechanism of action is similar to sofosbuvir’s. Ledipasvir targets a piece inside hepatitis C virus. This piece is called phosphoprotein NS5A. It is responsible for virus replication and construction. By targeting and inhibiting this protein, hepatitis C virus is powerless to replicate. Our immune system is thus given a chance to kill it of, which in most cases does very well.
It is also noteworthy that treatment with Hepcinat-LP does not need interferon; which in needed is some treatment cases with Sovaldi (drug only with sofosbuvir). This means that patients don’t have to use needles for interferon administration on daily basis.
Sofosbuvir and ledipasvir work synergetically to weaken hepatitic C replication. In such a way, virus is weakened. Immune system does the rest.
Now you can purchase Hepcinat-LP without the high cost of flying overseas. A savings of over $4,000.00 for travel alone, plus the $90,000 cost of the pills.